A woman considering medication for weight loss

New England Journal of Medicine

Volumn 375, Issue 12, 2016, Pages 1187-1189

  Yeh, James S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOREX; FENFLURAMINE; SIBUTRAMINE; ANTIOBESITY AGENT;

ARTICLE; BODY MASS; DIET THERAPY; DIETARY COMPLIANCE; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FOOD AND DRUG ADMINISTRATION; HEALTH BEHAVIOR; HUMAN; LIFESTYLE MODIFICATION; OBESITY; PHYSICAL ACTIVITY; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SHARED DECISION MAKING; WEIGHT CONTROL; WEIGHT REDUCTION; WOMEN'S HEALTH; ADULT; CASE REPORT; EXERCISE; FEMALE; LOW CALORY DIET; MULTIMODALITY CANCER THERAPY;

ADULT; ANTI-OBESITY AGENTS; COMBINED MODALITY THERAPY; DIET, REDUCING; EXERCISE; FEMALE; HUMANS; OBESITY; WEIGHT LOSS;

EID: 84988896072     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMclde1515935     Document Type: Article

References (11)

1. Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2015; 100: 342-62.
2. Gadde KM, Allison DB, Ryan DH, et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): A randomised, placebo-controlled, phase 3 trial. Lancet 2011; 377: 1341-52.
3. Smith SR, Weissman NJ, Anderson CM, et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med 2010; 363: 245-56.
4. Greenway FL, Fujioka K, Plodkowski RA, et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): A multicentre, randomised, double-blind, placebocontrolled, phase 3 trial. Lancet 2010; 376: 595-605.
5. Pi-Sunyer X, Astrup A, Fujioka K, et al. A randomized, controlled trial of 3. 0 mg of liraglutide in weight management. N Engl J Med 2015; 373: 11-22.
6. Garvey WT, Ryan DH, Look M, et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/ topiramate in obese and overweight adults (SEQUEL): A randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr 2012; 95: 297-308.
7. Schiff GD, Galanter WL, Duhig J, Lodolce AE, Koronkowski MJ, Lambert BL. Principles of conservative prescribing. Arch Intern Med 2011; 171: 1433-40.
8. Rasmussen N. America's first amphetamine epidemic 1929-1971: A quantitative and qualitative retrospective with implications for the present. Am J Public Health 2008; 98: 974-85.
9. Curfman GD, Morrissey S, Drazen JM. Sibutramine-another flawed diet pill. N Engl J Med 2010; 363: 972-4.
10. Padwal R, Li SK, Lau DC. Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev 2004; 3: CD004094.
11. Swinburn B, Kraak V, Rutter H, et al. Strengthening of accountability systems to create healthy food environments and reduce global obesity. Lancet 2015; 385: 2534-45.